NewGenIvf (NIVFW) Current Deferred Revenue (2022 - 2025)

NewGenIvf (NIVFW) has 4 years of Current Deferred Revenue data on file, last reported at $111981.0 in Q4 2025.

• In Q4 2025, Current Deferred Revenue rose 76.38% year-over-year to $111981.0; the TTM figure through Dec 2025 stood at $111981.0 (up 76.38% YoY), while the FY2025 annual figure was $111981.0, up 76.38% from the prior year.
• Current Deferred Revenue grew to $111981.0 in Q4 2025, from $63489.0 in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $1.4 million in Q4 2022 and bottomed at $7937.0 in Q4 2023.
• A 4-year average of $385893.8 and a median of $87735.0 in 2024 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue tumbled 99.42% — and 2024, when it jumped 699.91%.
• Year by year, Current Deferred Revenue stood at $1.4 million in 2022, then slumped by 99.42% to $7937.0 in 2023, then jumped by 699.91% to $63489.0 in 2024, then soared by 76.38% to $111981.0 in 2025.
• The last three Current Deferred Revenue figures came in at $111981.0 (Q4 2025), $63489.0 (Q4 2024), and $7937.0 (Q4 2023), per Business Quant data.

Peer Comparison